AUREGEN BIOTHERAPEUTICS
Auregen BioTherapeutics provides 3D bioprinting technology for innovative treatments to cure rare disorders.
AUREGEN BIOTHERAPEUTICS
Social Links:
Industry:
3D Technology Biotechnology Medical
Founded:
2016-12-01
Address:
Genève, Geneve, Switzerland
Country:
Switzerland
Total Employee:
1+
Status:
Active
Similar Organizations
Alia Therapeutics
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
Investors List
Gurnet Point Capital
Gurnet Point Capital investment in Venture Round - Auregen BioTherapeutics
More informations about "Auregen BioTherapeutics"
Auregen Biotherapeutics
At Auregen, we've spent over a decade exploring ingenious new processes and technologies to replace missing or lost tissue, with the goal of restoring human bodies to their original …See details»
About Auregen
At Auregen, we are boldly creating a new era of never-before-dreamed of medical advances, replacing the parts of ourselves we have lost to accident, disease, or nature for whole bodies, full lives, and infinite human potential. Founded in …See details»
Auregen BioTherapeutics - Crunchbase Company Profile & Funding
Auregen BioTherapeutics provides 3D bioprinting technology for innovative treatments to cure rare disorders.See details»
Auregen BioTherapeutics - LinkedIn
Auregen is proud to be a supportive partner of Ear Community, an impactful organization promoting education, advocacy and awareness, and bringing together families who are facing the challenges of ...See details»
Auregen Biotherapeutics Announces Appointment of Scott Lauder, …
8 hours ago Auregen Biotherapeutics, a clinical-stage company developing precision approaches to restore functional anatomy with cartilage cell therapy, today announced the …See details»
Auregen BioTherapeutics 2025 Company Profile: …
Information on valuation, funding, acquisitions, investors, and executives for Auregen BioTherapeutics. Use the PitchBook Platform to explore the full profile.See details»
Full List of Biotech Companies in Geneva (2025)
Feb 8, 2025 key biotech companies in Geneva are Amal Therapeutics, Light Chain Bioscience - Novimmune SA, Calliditas Therapeutic, Geneva Biotech, KBI Biopharma SA, and OM Pharma.See details»
Auregen BioTherapeutics - Funding, Financials, Valuation & Investors
Auregen BioTherapeutics provides 3D bioprinting technology for innovative treatments to cure rare disorders.See details»
Auregen BioTherapeutics SA in Genève | Moneyhouse
Mar 28, 2024 Auregen BioTherapeutics SA is a Company limited by shares (AG) with its legal headquarters in Genève. Auregen BioTherapeutics SA belongs to the industry «Research and …See details»
Auregen Biotherapeutics SA - Swiss Biotech
Beech Biotech is developing a novel treatment for preeclampsia, an severe unmet medical need that takes the lives of 70,000 women and 500,000 babies each year. The company is …See details»
Auregen BioTherapeutics SA - VentureRadar
Auregen BioTherapeutics SA VentureRadar profile. Find out more about Auregen BioTherapeutics SA, Biotech Pharma and Biotechnology.See details»
Auregen Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Auregen Biotherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Auregen BioTherapeutics SA - startup.ch
Auregen BioTherapeutics SA : Headquartered in Switzerland with facilities in Boston, Auregen is translating pioneering 3D bioprinting technology for innovative treatments for patients with rare …See details»
Auregen Biotherapeutics Announces Appointment of Scott Lauder, …
8 hours ago /PRNewswire/ -- Auregen Biotherapeutics, a clinical-stage company developing precision approaches to restore functional anatomy with cartilage cell therapy,...See details»
Auregen Bio Therapeutics SA - BioAlps
Provides 3D bioprinting technology for innovative treatments to cure rare disordersSee details»
Auregen BioTherapeutics - Crunchbase
Auregen BioTherapeutics, Tarsa Therapeutics, and Alia Therapeutics operate in the biotechnology and pharmaceutical sector. Auregen focuses on 3D bioprinting for rare …See details»
Patients - auregen.bio
At Auregen, we intend to change the way serious conditions are addressed through human tissue origination. We believe our first product, AUR-201, has the potential to transform microtia …See details»
Auregen Biotherapeutics is actively enrolling individuals with …
Mar 6, 2024 Last fall, Auregen began clinical trials on 3D printed regenerated ears that would help individuals born with unilateral microtia. Auregen Bio is actively enrolling individuals who …See details»
Auregen BioTherapeutics - Contacts, Employees, Board Members, …
Auregen BioTherapeutics provides 3D bioprinting technology for innovative treatments to cure rare disorders.See details»
Auregen Biotherapeutics Revenue, Growth & Competitor Profile
Future Competition: Auregen Biotherapeutics's Fastest Growing Competitors These companies are in the same general field as Auregen Biotherapeutics and are rapidly expanding. …See details»